1. Home
  2. BDTX vs ESSA Comparison

BDTX vs ESSA Comparison

Compare BDTX & ESSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDTX
  • ESSA
  • Stock Information
  • Founded
  • BDTX 2014
  • ESSA 1916
  • Country
  • BDTX United States
  • ESSA United States
  • Employees
  • BDTX N/A
  • ESSA N/A
  • Industry
  • BDTX Biotechnology: Biological Products (No Diagnostic Substances)
  • ESSA Banks
  • Sector
  • BDTX Health Care
  • ESSA Finance
  • Exchange
  • BDTX Nasdaq
  • ESSA Nasdaq
  • Market Cap
  • BDTX 161.6M
  • ESSA 192.5M
  • IPO Year
  • BDTX 2020
  • ESSA N/A
  • Fundamental
  • Price
  • BDTX $2.62
  • ESSA $20.20
  • Analyst Decision
  • BDTX Strong Buy
  • ESSA
  • Analyst Count
  • BDTX 4
  • ESSA 0
  • Target Price
  • BDTX $15.50
  • ESSA N/A
  • AVG Volume (30 Days)
  • BDTX 591.8K
  • ESSA 13.0K
  • Earning Date
  • BDTX 11-05-2024
  • ESSA 10-23-2024
  • Dividend Yield
  • BDTX N/A
  • ESSA 2.97%
  • EPS Growth
  • BDTX N/A
  • ESSA N/A
  • EPS
  • BDTX N/A
  • ESSA 1.81
  • Revenue
  • BDTX N/A
  • ESSA $68,480,000.00
  • Revenue This Year
  • BDTX N/A
  • ESSA N/A
  • Revenue Next Year
  • BDTX N/A
  • ESSA $6.92
  • P/E Ratio
  • BDTX N/A
  • ESSA $11.16
  • Revenue Growth
  • BDTX N/A
  • ESSA N/A
  • 52 Week Low
  • BDTX $2.09
  • ESSA $15.29
  • 52 Week High
  • BDTX $7.66
  • ESSA $21.50
  • Technical
  • Relative Strength Index (RSI)
  • BDTX 31.71
  • ESSA 57.12
  • Support Level
  • BDTX $3.16
  • ESSA $19.73
  • Resistance Level
  • BDTX $3.44
  • ESSA $21.50
  • Average True Range (ATR)
  • BDTX 0.22
  • ESSA 0.64
  • MACD
  • BDTX 0.03
  • ESSA 0.06
  • Stochastic Oscillator
  • BDTX 0.61
  • ESSA 54.39

About BDTX Black Diamond Therapeutics Inc.

Black Diamond Therapeutics Inc is a precision oncology medicine company. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.

About ESSA ESSA Bancorp Inc.

ESSA Bancorp Inc is a holding company, engaged in accepting deposits from the general public and investing those deposits, together with funds generated from operations and borrowings, in residential first mortgage loans (including construction mortgage loans), commercial real estate loans, home equity loans and lines of credit and commercial and industrial loans. The company offers a variety of deposit accounts, including checking, savings and certificates of deposit. The company also offers asset management and trust services and investment services. The company also offers insurance benefit consulting services through its wholly-owned subsidiary, ESSA Advisory Services, LLC.

Share on Social Networks: